首页> 外国专利> PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE

PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE

机译:减少致病菌致病性的分子

摘要

Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
机译:提供衍生自益生菌的肽,其已用于预防和/或治疗受试者的非肠感染。源自益生菌的肽也可用于降低受试者中非肠道感染的毒力。还提供了配制为食品,饮料,营养补充剂,药物等中或内部的肽的组合物。

著录项

  • 公开/公告号US2020017547A1

    专利类型

  • 公开/公告日2020-01-16

    原文格式PDF

  • 申请/专利权人 MICROSINTESIS INC.;

    申请/专利号US201816494429

  • 申请日2018-03-16

  • 分类号C07K7/06;A23L33/18;A23L33/195;A61L15/46;A61L27/54;A61L29/16;A61L31/16;C07K5/107;C07K5/113;

  • 国家 US

  • 入库时间 2022-08-21 11:23:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号